General Clinical Neuropsychiatry
P1. Akinetic mutism following anterior cerebral artery occlusion C. Alan Anderson, David B. Arciniegas, Daniel C. Huddle, Maureen Leehey (University of Colorado Health Sciences Center, Denver, CO)
Background: Akinetic mutism is a disturbance of motivation typically associated with bilateral mesial frontal lesions. Although the syndrome has been described with unilateral lesions, the pathophysiology is unknown. Case Report: A 61-year-old man presented to the emergency department with acute akinetic mutism. On examination, he was alert but inattentive. Spontaneous movement and speech were absent. With repeated prompting, he followed single-step commands only intermittently. Diagnostic neuroimaging studies were performed. An arteriogram demonstrated occlusion of the left anterior cerebral artery. MRI including diffusion-weighted sequences demonstrated an infarction in the distribution of the left anterior cerebral artery involving the cingulate gyrus and the left half of the corpus callosum. Conclusions: Although typically a consequence of bilateral anterior cingulate/callosal injury, the syndrome of akinetic mutism may also result from a lesion of the cingulate gyrus lesion in one hemisphere when extension into the body of the corpus callosum effectively disconnects the contralateral cingulate gyrus. This case is the first in vivo description of acute akinetic mutism produced by such a lesion.
P2. Is self-injurious behavior in patients with severe developmental disabilities an addiction? L. Jarrett Barnhill (University of North Carolina School of Medicine, Chapel Hill, NC)
Background: Self-injurious behavior (SIB) is a heterogeneous behavior that spans the range of psychiatric and neurological disorders. SIB may occur in 15% to 20% of patients with autism and severe developmental disabilities. Some milder forms of SIB are related to high rates of repetitive behaviors. Severe SIB appears driven and compulsive, and it continues in spite of severe tissue damage. Both subtypes share characteristics with addiction behaviors. Methods: Case studies will be provided from the Developmental Neuropharmacology Clinic and multiple residential programs for patients with severe developmental disabilities. The typology of SIB will be compared with addiction behaviors. Results: Milder forms of SIB resemble stereotypies and compulsive spectrum disorders. They appear to be preceded by an urge to perform the repetitive behavior, and they appear intrinsically reinforcing. Severe SIB can be compulsive and relentless, and even severe pain fails to interrupt the behavior. For many patients, pain or specific environmental or affective states trigger the SIB, but once initiated, it continues in an out-of-control fashion. Conclusions: SIB has features consistent with drug addiction. Milder forms of SIB (high frequency/low intensity) resemble the early phases of drug abuse. More severe SIB shares features of progressive addiction: craving, loss of control, tolerance to intrinsic reinforcement, and sensitization. The discussion will focus on the similarities between SIB and sensitization from chronic psychostimulant abuse and the common ground between neurobiological substrates and treatment strategies.
P3. Vagal nerve stimulation for medically refractory epilepsy in persons with severe developmental disorders L. Jarrett Barnhill, Sue Lannon, Bradley Vaughn (University of North Carolina School of Medicine, Chapel Hill, NC)
Background: Medically refractory epilepsy, developmental brain abnormalities, and neurobehavioral disorders are commonplace in individuals with severe developmental disabilities. Vagal nerve stimulation (VNS) is a promising strategy for refractory epilepsy and mood disorders in patients with developmental disabilities. Methods: This study included 31 autistic and intellectually disabled patients who received a VNS. We compared changes in seizure frequency and neuropsychiatric status at baseline with one-year post-VNS follow-up. Results: Of the 31 patients who received a VNS, 15 had slight or moderate reduction in seizure frequency. Few patients were able to discontinue or decrease doses of their antiepileptic drugs. Neurobehavioral deterioration occurred in 6/12 VNS nonrepsonders and 5/6 patients with comorbid autism. Negative behavioral outcomes included increased irritability/moodiness, aggression, and social withdrawal. Conclusions: VNS is an exciting technique for patients with medically refractory epilepsy. In our heterogeneous sample, VNS appeared partially effective in 15/31 patients. Improvements in quality-of-life measures occurred with reductions in seizure frequency and included increased alertness as well as reduced frequency. Our results suggest that clinical improvement with VNS is less predictable in patients with severe developmental disabilities. Patients with comorbid autism appear at greater risk for neurobehavioral complications.
P4. Levodopa treatment for tics: preliminary report Kevin I. Black, Johanna M. Hartlein, Bradley L. Schlaggar, Jonathan W. Mink (Washington University School of Medicine, St. Louis, MO; University of Rochester, Rochester, NY)
Background: Because of the clear response of tics to neuroleptics, it was initially thought that tics reflected dopaminergic hyperactivity. However, tics do not diminish if comorbid Parkinson's disease develops, and we recently reported that a single-blind acute dose of levodopa 150 mg actually diminished tic severity by an average of 40% in 6 adults with TS. This is an interim report from a randomized controlled trial. Methods: 17 volunteers with Tourette syndrome or chronic motor tic disorder, with no recent neuroleptic treatment, have enrolled thus far in a double-blind treatment study. Levodopa/carbidopa 100/25 mg, or matching placebo, is given in doses of 0.5–2.0 tabs po tid (0.5–1.0 in prepubescent children). Results: Seven patients are ages 8–17 and 10 are adults. Complete data through the first 8 weeks of treatment are available from 13 subjects, except that we remain blind to drug assignment. Three subjects were withdrawn because of noncompliance (one after week 8), and 2 dropped out due to worsened impulsivity or anger. Possible side effects in the other 12 subjects have been mild and include nausea (1), transient hypertension (1), migraine (in a subject being treated for migraines), and mild worsening of tics (1). Clinical global impression of tic change by a blinded physician rater ranged from 2 in one subject to 5 in two subjects, with a mean of 3.7 (2=moderate improvement, 3=minimal improvement, 4=unchanged, 5=minimal worsening). Pill counts were consistent with excellent compliance in 10 of 13 subjects. Mean self-rated tic severity improved slightly from 17.8 at baseline to 13.8 at week 8. Conclusions: Consistent with our earlier report, substantial doses of levodopa do not cause significant worsening of tics. This finding does not support a hypothesis that tics result from dopaminergic hyperactivity. Further analysis awaits eventual unblinding.Support from Tourette Syndrome Association and NINDS.
P5. Aggressive behavior after a recent stroke: initial findings and six-month follow-up Keen-Loong Chan, David Moser, Stephan Arndt, Robert G. Robinson (University of Iowa, Iowa City, IA; Tan Tock Seng Hospital, Singapore)
Background: Aggression is often seen in neuropsychiatric conditions. We attempted to determine the correlates of aggression after stroke and to follow up on the progression over 6 months. Methods: 92 patients with recent stroke were assessed for aggression on the basis of symptoms elicited by the Present State Examination (PSE). Aggressive patients were compared with nonaggressive patients on total PSE scores, Ham-D, Ham-A, MMSE, Johns Hopkins Functioning Inventory, psychiatric symptoms, frontal-executive functions, and CT scan findings. Results: 25% (23/92) of patients were aggressive. Aggressive patients had higher total PSE, Ham-D, and Ham-A scores, lower MMSE scores, and lesions that were more proximal to the frontal pole of the brain than nonaggressive patients. There were no differences in tests of frontal-executive function or measures of brain atrophy. Stepwise regression showed that Ham-A and lesion proximity to the frontal pole were significant in predicting aggression. By 6 months, most (22/23) of the aggressive patients had improved in their aggression, irrespective of treatment with antidepressant or placebo. Conclusions: In the majority of cases, early-onset aggression after a recent stroke appears to improve irrespective of treatment with antidepressant or placebo. Because anxiety significantly predicted aggression, more research is needed to determine if treatment with anxiolytics would reduce the incidence and severity of aggressive behavior after stroke.Support from NIMH Grants MH40355, MH52879, and MH53592.
P6. Evolution of primary progressive aphasia due to Alzheimer's disease David G. Clark, Mario F. Mendez* (University of California at Los Angeles, Los Angeles, CA)
Background: In primary progressive aphasia (PPA), there are isolated and progressive language deficits for at least two years prior to possible dementia (Neary et al, Neurology 1998; 51:1546–1554). The two major forms of PPA are a nonfluent aphasia and a fluent “semantic dementia” with loss of word meaning. The most common pathology in PPA is frontotemporal dementia, but approximately 20% have Alzheimer's disease (AD). We describe an AD patient who evolved from semantic dementia to nonfluent aphasia to reiterative speech. Case Report: A 70-year-old man presented with language deficits consistent with semantic dementia. He had a fluent and grammatical speech, paraphrasias, and impairments in naming and word comprehension. Over the next few years he developed hesitant, broken, telegraphic, and effortful speech. Near the end of his life, he had dysarthria, palilalia, and profound stuttering such that all he could utter were the first syllables of words. On autopsy, he had AD with neurofibrillary tangles and senile plaques involving the language areas. Conclusions: In AD, the syndrome of PPA can evolve through a spectrum of speech and language difficulties when pathology involves the perisylvian language areas. We discuss the diagnosis of PPA and management with speech therapy and dopaminergic drugs.
P7. Acute frontotemporal personality from hypoxic encephalopathy Nima A. Fahimian, Margaret Swanberg, Mario F. Mendez* (University of California at Los Angeles, Los Angeles, CA)
Background: Severe disinhibition and the symptoms of the Klüver-Bucy syndrome are manifestations of frontotemporal dementia. Other conditions may cause these behavioral changes. We report an unusual case of a man with severe frontotemporal behaviors due to hypoxic encephalopathy. Case Report: An 82-year-old man was in his usual state of health when he awoke with an acute personality change associated with a probable cardiac arrhythmia. He went from being an introvert to an extravert and showed decreased impulse control with verbal outbursts. He became hypersexual and would demarcate his living room with feces. He exhibited hyperoral behaviors, hypermetamorphosis, labile mood and exophoria, and a tendency to explore by touching. The patient underwent neurobehavioral and neurological examinations and imaging studies. Examination disclosed evidence of frontal-executive deficits, attention difficulty, and frontal grasp reflexes. MRI revealed generalized atrophy, and PET showed hypometabolism more prominent in bilateral superior temporal gyrus followed by frontal regions. Conclusions: This patient illustrates the dramatic development of frontotemporal personality including the spectrum of frontal changes and anterior temporal Klüver-Bucy symptoms. We discuss the differential diagnosis of frontally predominant behavior changes and the Klüver-Bucy syndrome, in this case most consistent with postanoxic dystrophy.
P8. Critical periods of suicide risk in Huntington's disease Karin C. Ferneyhough, Laura M. Stierman, Beth M. Turner, Jane S. Paulsen,* and the Huntington Study Group (University of Iowa, Iowa City, IA)
Background: It is well established that suicide risk in patients with Huntington's disease is greater than that in the general population. No known large-scale study has examined differences in suicide risk across stages of HD. Methods: Suicidal ideation was examined in 4,342 individuals in the Huntington Study Group database. All subjects were grouped according to the standardized neurological exam from 0 (normal exam) to 3 (unquestionable HD). Patients with an unequivocal diagnosis of HD were further divided into stage of disease (stage 1 to stage 5) by using Shoulson and Fahn's total functional capacity measure. Results: The proportion of persons with suicidal ideation varied by diagnosis and HD stage, suggesting two primary critical periods during which suicidal ideation increased dramatically. The frequency of suicidal ideation doubled from 10.4% in at-risk persons with a normal neurological exam to 20.5% in at-risk persons with soft neurological signs (χ2=40.99, P<0.001). In persons with a diagnosis of HD, 15.7% had suicidal ideation in Stage 1, whereas 20.9% had suicidal ideation in Stage 2 (χ2=20.10, P<0.001). Conclusions: Findings suggest two critical periods for increased suicide risk in HD. Although the underlying mechanisms of suicide risk in HD are poorly understood, it is beneficial for health care providers to be aware of periods during which patients may be at an increased risk for suicide. Support from the Huntington's Disease Society of America, Huntington Study Group, and Hereditary Disease Foundation.
P9. Geriatric treatment center: a contemporary model for collaboration between psychiatry and neurology Christopher M. Filley, David B. Arciniegas, G. Vernon Wood, C. Allen Anderson, Elizabeth Cheney, Charles R. Dygert, Lanier Summerall, Robert B. Goos (University of Colorado Medical School, Denver, CO)
Background: The diagnosis and treatment of individuals with problems involving both psychiatry and neurology have become more sophisticated in recent years, but these advances may be difficult to implement in the modern health care environment. Methods: For the past 16 years, we have employed an inpatient geriatric facility within a state mental hospital to diagnose and treat older persons with complex neuropsychiatric disorders. We present 8 illustrative cases to describe the Geriatric Treatment Center and the procedures used for the care of these challenging patients. Results: All individuals presented with major behavioral dysfunction that could not be managed effectively in other health care facilities. As a result of detailed neuropsychiatric evaluation and behavioral neurology consultation, all had neurologic diagnoses clarified or confirmed as the cause of their presentation. Seven of the patients improved with appropriate treatment, of whom one could be discharged to the community. The eighth patient died and had an autopsy diagnosis of his disease at a nearby academic medical center. Conclusions: This series highlights the value of collaboration between psychiatry and neurology for the evaluation and treatment of older patients with neuropsychiatric problems that are not easily accommodated by many existing health care settings.
P10. Are nonverbal learning disabilities specific types of learning disabilities? Yitzchak Frank, Thomas Pawlcyk, Jessica Seiden (Neurobehavioral Program, North Shore University Hospital, New York University Medical School, New York, NY)
Background: Nonverbal learning disability (NVLD) is a syndrome with features reminiscent of acquired right hemisphere lesions. Subjects have a marked disparity between a higher verbal and a lower performance IQ. Learning difficulties involve mathematical more than reading skills. Visuospatial, attentional, and social communicative skills are impaired. We aimed to determine which aspects of NVLD differentiate it from other types of learning disability. Methods: 70 children and adolescents ages 8 to 15 years evaluated in our program had the following: Wechsler Intelligence Scale for Children–Revised (WISC-R) or WISC-III; a DSM-IV-compatible attention questionnaire (SNAP IV); Achenbach's Child Behavior Checklist and Teacher's Report Form (TRF); a continuous performance test (TOVA), and standardized achievement tests. A designation of NVLD required VIQ scores higher than PIQ scores by at least 12 points and Full Scale IQ score not lower than 85. The following three groups were compared: NVLD, language-based LD, and nonspecific LD. Results: Group differences (P-values reported) were found in the following: WISC-III: Similarities (0.0048), Vocabulary (0.0001), VIQ (0.0001); Achenbach TRF: Total (0.0131), Externalizing (0.032); Teachers' SNAP IV: Inattention (0.019), Hyperactivity/Impulsivity (0.04), Oppositional Defiant Disorder (0.04); TOVA scales: Omission (0.018), Commission (0.009), Response time (0.0069), Variability (0.011); achievement tests: reading comprehension (0.0001), and math (0.0474). These results suggest specific profiles for NVLD.
P11. Specificity of neurological and neurocognitive function in children with attention-deficit/hyperactivity disorder Shur-Fen Susan Gau, James R. Merikangas, Kathleen R. Merikangas (Yale University, New Haven, CT)
Background: Previous studies of clinical samples of children with attention-deficit/hyperactivity disorder have suggested that ADHD may be associated with a range of neuropsychologic and neurologic deficits. The objective of this study was to examine the neuropsychiatric correlates of ADHD and their specificity in a nonclinical sample. Methods: Subjects included 203 offspring ages 7 to 18 of parents with substance use disorders; parents with anxiety/depression; and control subjects in a longitudinal family study. Among them, 35 were children with a DSM-III-R diagnosis of ADHD. A comprehensive battery of structured measures of psychiatric, neurologic, and neuropsychologic function was administered blindly by experienced clinicians. Results: After controlling for parental disorders, perinatal factors, comorbid psychiatric disorders, and sociodemographic variables, children with ADHD were more likely than those without ADHD to have lower IQ, shorter spatial memory span, minor physical anomalies (particularly high-arched palate), abnormal MMSE, and abnormal fine motor movements and associated movements on neurologic examination. Integration of these findings revealed that freedom from distractibility (Wechsler) and associated movements were the leading factors discriminating children with ADHD from those with other or no psychiatric disorders. Conclusions: The characteristic neuropsychiatric deficits in these children may inform studies of the neural pathways underlying ADHD and of potential etiologic mechanisms. These findings also suggest the importance of early intensive educational intervention.
P12. EEG findings in women with premenstrual syndrome Frances Hagaman, Mary Jo Fitzgerald, John McWilliams, Margaret Read, Anita Kablinger (Louisiana State University Health Sciences Center, Shreveport, LA)
Background: Changes in the electroencephalogram (EEG) related to the menstrual cycle have been investigated since the 1930s. Authors have found an increase in total power of the alpha range around ovulation (Gautray et al, Acta Eur Fertil 1970; 5–13), and acceleration in alpha rhythms during the luteal phase (Creutzfeld et al, Electroencephalogr Clin Neurophysiol 1976; 128:113–129). Premenstrual syndrome (PMS) represents a cluster of symptoms found in many women during the luteal phase of their cycle. We hypothesized that abnormal EEGs would be found in women who experienced severe PMS. Methods: 81 females between 18 and 40, with regular menstrual cycles, were recruited through newspaper advertisements. All women underwent a psychological interview, completed the Premenstrual Assessment Form (PAF) and the lifetime version of the Schedule for Affective Disorders and Schizophrenia (SADS), and had an EEG. 45 patients completed assessments and met inclusion criteria. Results: Subjects were divided into low, medium, and high PMS groups based on PAF scores. A high number of subjects demonstrated paroxysmal dysrhythmias (PD) despite the severity of PMS symptoms. Subjects who had PD were compared with those having normal EEGs in terms of specific PMS symptoms. Although this study has limitations, the increased prevalence of EEG abnormalities is intriguing.
P13. Amantadine for psychostimulant-resistant attention-deficit/hyperactivity disorder in boys Joseph P. Horrigan, L. Jarrett Barnhill (University of North Carolina, Chapel Hill, NC)
Background: Psychostimulants represent the gold standard of treatment for ADHD. However, they are effective in only 70% to 75% of cases. This study evaluated the safety and efficacy of amantadine hydrochloride for ADHD. Methods: 16 boys (mean age 9.6 years) who attended a residential school participated in this 16-week trial. Each had failed to respond to at least two prior psychostimulant trials. Amantadine was initiated as monotherapy in an open-label manner, at a dose of 100 mg po bid (breakfast, lunch). A further 100 mg was added at 3:00 p.m. after 2 weeks if only a partial response was noted. Results: All 16 boys completed the trial. Few side effects were noted. 13 of the 16 (81%) were classified as positive responders (>30% decrease in the baseline teacher-rated Conners Global Index score and a clinician-generated clinical global impression Improvement score of 1 or 2). The mean effective dose was 262.5 mg/day. Tolerance to amantadine was noted in 7 cases, which was overcome in each instance via a 4-day drug holiday and subsequent rechallenge with the previously effective dose. Conclusions: Amantadine may be a useful addition to the pharmacotherapeutic armamentarium for ADHD, particularly in psychostimulant-resistant cases. Tolerance is a potential problem that appears to be easily managed.
P14. Charles Bonnet syndrome with visual hallucinations of infantile memory: a case report Kazuhisa Maeda, Ryouko Ishikura, Takefusa Nagami, Shu Nukina, Shin-ichi Yoshioka, Ryuzo Kawahara (Tottori University, Yonago, Japan)
Background: Charles Bonnet syndrome (CBS) is a condition in which individuals experience complex visual hallucinations without demonstrable psychopathology or disturbance of normal consciousness. Here we report a case of CBS with visual hallucinations of infantile memory and successful treatment of CBS with using risperidone. Case Report: A 57-year-old woman with a history of depression and diabetes mellitus was admitted to our hospital because of diabetic neuropathy and cataract. Her visual acuity was distinguishing hand movement in the right eye and 0.04 in the left eye. After 7 days of cataract surgery, she experienced visual hallucinations that took the form of a scene of building construction. She maintained insight into the unreal nature of the visions. She realized that she had experienced the scene in childhood. CT and EEG examination revealed no remarkable changes. After 1 week of treatment with 1 mg of risperidone daily, all of her visual hallucinations disappeared. Conclusions: Despite numerous case reports, there are few reports of CBS with visual hallucinations of infantile memory and few successful methods of treatment of CBS. In the case reported here, we successfully treated the condition with the atypical neuroleptic risperidone.
P15. Social cognition deficits in patients with frontal lobe damage Linda Mah, Miriam Courtney Arnold, Jordan Grafman (Cognitive Neuroscience Section, NINDS, Bethesda, MD)
Background: Patients with damage to the frontal lobes frequently exhibit impaired social behavior, despite preservation of language, memory, and perception. This clinical observation has received little systematic evaluation. We studied social cognition in patients with frontal lobe lesions, using the Interpersonal Perception Task (IPT), a standardized method of assessing the accuracy of social judgments regarding videotaped interpersonal situations. Methods: We administered the IPT to patients with lesions involving prefrontal cortex (FLL; n=33) and healthy normal control subjects (n=32). All FLL patients had sustained penetrating head injuries, except for 2 who had aneurysms and 1 with an astrocytoma. Results: FLL subjects performed more poorly on the IPT compared with normal control subjects (P=0.001). They showed specific deficits when making judgments of kinship (P=0.034), determining the veracity of statements (P=0.012), and inferring which individual had competed successfully against the other (P=0.031). FLL patients also tended to overestimate the accuracy of their performance on the IPT compared with the self-ratings of normal control subjects (P=0.06). Conclusions: Patients with damage to prefrontal cortex are impaired in their ability to interpret the nature of social interactions.
P16. Phenomenological and psychopharmacological characteristics of obsessive-compulsive disorder patients with musical obsessions T. Matsui, H. Matsunaga, K. Ohya, Y. Iwasaki, K. Koshimune, A. Miyata, N. Kiriike (Department of Neuropsychiatry, Osaka City University Medical School, Osaka, Japan)
Background: Intrusive nonsense sounds or music have rarely been reported and discussed in patients with OCD. In practice, drawing a distinction between musical obsessions and musical hallucinations is considered rather difficult. Methods: Clinical features in 2 cases of patients with musical obsessions are presented to discuss phenomenological and psychopharmacological differences from those in patients with musical hallucinations. Results: Despite no covert or systematic compulsive behaviors, the musical symptoms in the present cases are consistent with the phenomenological nature of OCD defined in DSM-IV. In addition, in contrast to previous case reports of musical hallucinations, the present patients failed to respond to neuroleptics but showed significant response to an adequate trial of clomipramine. Conclusions: These symptoms appear to be phenomenologically and biologically distinct from musical hallucinations, especially those characteristic of schizophrenia. However, taking into account the clinical similarities between musical obsessions and musical hallucinations, there may be a number of patients whose musical symptoms could lead to confusion in diagnosis or treatment strategy, and those patients should be treated with caution.
P17. Foreign accent syndrome following a stroke in the corpus callosum Deborah A. Mueller, C. Alan Anderson, Richard L. Hughes, Jill Newcombe (University of Colorado, Denver, CO)
Background: Foreign accent syndrome is a rare constellation of speech anomalies that manifests in a perceived foreign accent. The speech disorder is variable, and only 15 patients have been described in the literature. The etiology of the syndrome is usually stroke or trauma to the left prerolandic motor cortex, the frontal motor association cortex, or the striatum (Kurowski et al, Brain Lang 1996; 54:1–25). Methods: We studied a 54-year-old female who was referred after acute onset of speech difficulties. Results: The patient had a mild receptive aphasia and a French-sounding accent on examination. She had stiff and distorted articulation with frequent hesitancies and paraphrasias. Prosody, praxia, fluency, and volume were all normal. MRI revealed a 1.7-cm hyperintense lesion in the left midportion of the corpus callosum. Conclusions: It was theorized that foreign accent syndrome and other speech disorders could result solely from a disruption of frontal efferent fibers passing across the corpus callosum (Schiff et al, Arch Neurol 1983; 40:720–727). Although the syndrome itself comprises a heterogeneous group of patients with different speech anomalies and localizations, this case may allow us to further elucidate the pathways that are important in producing normal speech patterns.
P18. Meta-analyses of poststroke depression and lesion location: a reappraisal Kenji Narushima, Todd Kosier, Robert G. Robinson* (Department of Psychiatry, University of Iowa College of Medicine, Iowa City, IA)
Background: In 1981, we first reported a significant correlation between proximity of left hemisphere stroke lesion to the frontal pole as measured on computed tomography and severity of depression. Since that time there have been numerous replications as well as failed replications, and a meta-analysis in 2000 concluded there was no evidence to support the association of depression with lesion location following stroke. Methods: Journals published from 1981 to 2000 were reviewed. We 1) did a computer-based journal search, 2) used references of reviews and reports, and 3) hand searched the latest key journals. The inclusion criteria required standardized criteria for depression, appropriate imaging, and less than 6 months' interval between stroke and neuropsychoanatomical measurements. Results: 99 reports were identified by the search strategy. 15 reports were eligible for inclusion. Both fixed and random model analyses showed that the association stated above was significant regardless of the side of stroke. Conclusions: This study supported our hypothesis that there is a significant inverse correlation between the severity of depression and the distance of the anterior border of the lesion from the frontal pole up to 6 months following stroke.Support from NIMH Grants MH40355, MH52879, MH53592, and Research Scientist Award MH00163.
P19. Rates of depressive symptoms in presymptomatic Huntington's disease C. Nehl, M. Benjamin, J.S. Paulsen,* and the Huntington Study Group (University of Iowa, Iowa City, IA)
Background: It is well established that Huntington's disease is associated with increased levels of depression, although psychopathology in presymptomatic HD has not been adequately studied. Methods: Depressive symptoms, as measured by the depression factor of the Unified Huntington's Disease Rating Scale, were assessed in 2,840 individuals diagnosed with HD and 77 individuals presymptomatic (but having the gene mutation) for HD. All data were obtained from the Huntington Study Group database. Results: A larger proportion of presymptomatic than of diagnosed individuals reported symptoms of sad mood (χ2=83.19, P<0.0001), anxiety (χ2=49.97, P<0.0001), and low self-esteem (χ2=96.93, P<0.0001). Among individuals presymptomatic for HD, 48.6% reported sad mood, 47.3% reported anxiety, and 33.8% reported low self-esteem. In diagnosed individuals, 39.9% reported sad mood, 40.5% reported anxiety, and 24.9% reported low self-esteem. Conclusions: A large proportion of presymptomatic individuals reported depressive symptoms. Further, a significantly larger proportion of presymptomatic individuals showed depressive symptoms compared with individuals having a confirmed diagnosis of HD based on abnormal movements. Further research is required to determine whether differences in rates of depression are attributable to general disease development, adaptation to illness, or reduced awareness of mood.Support from the Huntington's Disease Society of America, Huntington Study Group, and Hereditary Disease Foundation.
P20. Catatonia following acute dopamine depletion R. Nehru, N. Ahuja (Neurobehavior Clinic, GB Pant Hospital, New Delhi, India)
Background: Several reports in the literature demonstrate that catatonia may be induced by neuroleptics, and catatonia may precede or follow the neuroleptic malignant syndrome (NMS), suggesting that catatonia might be a hypodopaminergic state. We present direct evidence in favor of this contention. Case Report: A 51-year-old female Parkinson's disease patient developed multiple catatonic signs preceding a full-blown acute dopamine depletion syndrome (ADDS) with altered sensorium, massive extrapyramidal rigidity, hyperthermia, autonomic disturbance, and markedly elevated serum creatine phosphokinase, following planned reduction of levodopa therapy for dopa-dyskinesias. She was still recovering with restoration of levodopa dosage and addition of bromocriptine when she again developed catatonia following inadvertent reduction in her dosage. She never received any dopamine antagonists and did not receive lorazepam or ECT for treatment of catatonia. Catatonia appeared twice following withdrawal of levodopa in this case. It resolved on both occasions, along with the ADDS, following restoration of levodopa and addition of bromocriptine. Conclusions: Observations suggest that both NMS (functionally equivalent to ADDS) and catatonia are hypodopaminergic states, and that both lie on the same spectrum of disorders. Hypodopaminergia may be the fundamental neurochemical denominator in catatonia, along with secondary or consequential perturbations of other transmitter systems.
P21. Hypersexuality following right pallidotomy for Parkinson's disease Susan M. O'Connor, Gerald T. Lim, Mario F. Mendez* (University of California at Los Angeles, Los Angeles, CA)
Background: Sexual behavior is mediated by the hypothalamic preoptic nuclei and the septal nuclei and is modulated by frontal and temporal lobes. The role of the globus pallidus (GP) in sexual expression is less clear. We report a patient with marked hypersexuality following right pallidotomy for intractable Parkinson's disease. Case Report: Immediately after right pallidotomy, a 59-year-old man began demanding of his wife of 41 years coital activity up to several times per hour. He masturbated constantly and nearly bankrupted his family from spending on prostitutes, strippers, and pornography. He propositioned his wife's female friends and was allegedly sexually inappropriate with his granddaughter. Review of his PD medications did not disclose a correlation with his hypersexuality. On examination, the patient endorsed increased sexual interest but was not distressed by it. Mental status was otherwise normal. Pallidotomy relieved his tremor and gait disturbance, but he remained with mild rigidity and bradykinesia. MRI showed a discrete lesion in the right GP. His hypersexuality responded to valproate therapy. Conclusions: This patient developed hypersexuality after right pallidotomy. Rauch et al. (Psychiatry Res 1999; 91:1–10) report increased blood flow in ventral GP during sexual arousal, further suggesting that the GP participates in the neurocircuitry of sexual behavior.
P22. The Charcot-Willibrand syndrome from anoxic encephalopathy Alireza Pakkar, Gerald T. Lim, Mario F. Mendez* (University of California at Los Angeles, Los Angeles, CA)
Background: The loss of visual imagery is known as the Charcot-Willibrand syndrome. Patients with this condition have lost the ability to represent images visually in their mind. We report a patient with this rare syndrome. Case Report: A 69-year-old man with depression attempted suicide by hanging himself. He was found unconscious and transferred to intensive care with presumed anoxic brain injury. After recovering, he complained of inability to visualize objects, faces, or routes and could not remember details of complex figures and faces, including his own face. He described his mind as visually blank and complained of inability to see himself in his dreams. On examination, mental status was normal. Memory, language, and executive functions were also normal. On visual testing, he could not describe from memory the visual features of complex images, objects, or faces but had no problem recognizing and matching these images. There was no evidence of visuoperceptual deficits, visual agnosia, visuospatial impairment, prosopagnosia, or environmental disorientation. MRI of brain showed mild cerebral and cerebellar atrophy. Conclusions: This rare syndrome of defective revisualization results from presumed parietal lobe injury. This patient illustrates a postanoxic etiology for the Charcot-Willibrand syndrome and its dissociation from other visuoperceptual deficits.
P23. Neurobehavioral disorders in pediatric epilepsy Gustavo J. Rey, Leanne Shapiro, Trevor J. Resnick, Michael Duchowny, Prasanna Jayakar (Neuroscience Center, Miami Children's Hospital, Miami, FL)
Background: Existing data indicate a significantly higher frequency of behavioral disorders in children with epilepsy relative to the general population. Yet there is a dearth of pediatric studies assessing the relationship between clinical-neurological? variables and psychiatric comorbidity in this group. Methods: We examined 22 children referred to a tertiary epilepsy center. The sample had a mean age of 12.8 years (SD=3.9) and was equally divided as to gender. Average age at onset was 4.0 years (SD=3.2), and mean seizure frequency was 14.22 episodes/week. Some of the subjects had intractable epilepsy and were being examined for epilepsy surgery candidacy. Results: 45% of the sample had a Full Scale IQ within the mentally retarded range. There was a high prevalence of behavioral disorders, with 40% demonstrating clinically significant social/interpersonal problems and 32% presenting symptoms of ADHD. Age at onset, seizure frequency, presence/absence of an identifiable lesion, and lateralization of EEG findings were not related to intellectual and behavioral status. Conclusions: Our study revealed a high prevalence of intellectual deficiencies and behavioral disturbances in a heterogeneous pediatric epilepsy sample. Larger studies using more homogeneous samples are needed to understand the neurological substrates of these associated psychiatric disorders in epilepsy.
P24. Depressive symptoms in Parkinson's disease are underrecognized Irene H. Richard, Anne W. Justus, Eric Caine, Roger Kurlan (University of Rochester, Rochester, NY)
Background: Depression in Parkinson's disease is associated with increased disability (Liu et al, J Neurol 1997; 244:493–498) and reduced quality of life (Kuopio et al, Mov Disord 2000; 15:216–223). Methods: 100 PD patients and 42 spouses were invited to answer questions about their psychiatric history and medications and to complete the 13-item Shortened Beck Depression Inventory (S-BDI) and the Geriatric Depression Rating Scale (GDS). Results: 76 patients and 15 spouses participated. 40 (53%) of the patients, but no spouses, scored within the mildly depressed range or higher on the S-BDI (>7) and/or the GDS (>9). 24/40 (60%) denied ever being diagnosed with depression or treated with antidepressants. Seven patients (9%) scored within the severely depressed range on the S-BDI (>10) and moderate–severe range on the GDS (>20). Only 1/7 reported a history of depression diagnosis and was taking an antidepressant. Conclusions: It will be important to confirm diagnoses of depression with face-to-face interviews, but these results suggest that many PD patients suffer from unrecognized and potentially treatable depressive symptoms.Support from NINDS and NARSAD.
P25. Are delirium and dementia different? Paula T. Trzepacz, Dinesh Mittal, Rafael Torres, Kim Kanary, John Norton, Nita Jimerson (University of Mississippi Medical Center, Jackson, MS; Lilly Research Laboratories, Indianapolis, IN)
Background: This study compared phenomenological differences between DSM-IV delirium (DEL) and dementia (DEM), using two validated scales specifically designed for use in delirium. Methods: Ratings on the Delirium Rating Scale-Revised-98 (DRS-R-98) were done by psychiatrists blind to diagnosis and to Cognitive Test for Delirium (CTD) scores. Items on the DRS-R-98 and CTD were compared by using nonparametric tests between DEL (n=24) and DEM (n=13) groups. Results: Overall scores on the CTD (P<0.05) and DRS-R-98 (P<0.001) were worse in DEL than DEM. CTD items for orientation, memory, and vigilance did not differ. Comprehension was the only CTD item significantly worse in DEL than DEM (P=0.009), although attention span showed a trend (P=0.076). CTD comprehension correlated with DRS-R-98 total score (r=–0.58, P=0.003) in the DEL group. On the DRS-R-98, DEL had significantly higher scores (more impairment) for sleep-wake cycle disturbance (P<0.001), perceptual disturbance (P=0.006), thought processes (P=0.003), lability of affect (P=0.009), motor agitation (P<0.001), attention (P=0.001), and visuospatial ability (P<0.001), as well as for the three diagnostic items: temporal onset of symptoms (P<0.001), fluctuation of symptoms severity (P<0.001), and physical disorder (P<0.001). There were no significant differences for DRS-R-98 delusions, language, motor retardation, orientation, short-term memory, or long-term memory, however. Conclusions: Both the Cognitive Test for Delirium and DRS-R-98 found comparable deficits in orientation and memory in DEL and DEM but detected more impaired attention in DEL. These findings support DSM criteria for cardinal attentional impairment in delirium, but not for memory deficits unique to dementia. All three DRS-R-98 diagnostic items distinguished DEL from DEM, supporting empirical literature. DRS-R-98 identified more distinguishing symptoms than previous reports (Liptzin & Levkoff), which could highlight underlying neural differences between delirium and dementia. Delusions, language, motor retardation, orientation, and short- and long-term memory were comparably impaired in DEL and DEM.Support from the Mental Illness Research Education and Clinical Center, Veterans Integrated Service Network 16 (MIRECC-VISN 6), Department of Veterans Affairs.
P26. An investigation of the psychological functioning and suicide risk among relapsing-remitting multiple sclerosis patients Yakov Vardi, Zoli Zlotogorski, Yoram Finkelstein (Shaare Zedek Medical Center, Jerusalem, Israel)
Background: Research has reported depressive symptomatology and affective lability among multiple sclerosis patients (Fisk et al, Can J Neurol Sci 1998; 23:230–235). Of particular concern are the reported higher suicide attempts for this population. Methods: 28 nonmedicated patients with relapsing-remitting MS (Expanded Disability Status Scale mean ∼3.5) in the remitting phase were administered projective tests. The 16 women and 12 men who participated in the study had a mean age of 39 and 14 mean years of education. Exner's comprehensive system of administration and scoring was employed to ensure reliability and validity. Results: The MS sample differed significantly from the normative sample on nearly all personality variables. Our findings suggest that MS patients may suffer from a thought disorder, not previously reported, that is comorbid with the affective disorder. More important, the MS population evidenced a higher suicide risk on the suicide potential measure, which seems to be related also to the thought disorder. SPECT study of these patients showed hypoperfusion of the left prefrontal region. Conclusions: Higher risk of suicide in MS patients is related to thought disorder no less than to the depressive state.
P27. Episodic supernumerary phantom limb due to epileptic disruption of the neural representation of the body image Aaron Weisbord, Jeffrey L. Saver,* Megan C. Leary (University of California at Los Angeles, Los Angeles, CA)
Background: The phantom limb syndrome is a common sequela of limb amputation. Rarely reported is the sensation of having extra appendages, the supernumerary phantom limb syndrome or pseudopolymelia. Case Report: A 78-year-old female complained of 10 days of episodes of tingling and numbness in the left arm, followed by the subjective sensation of a second left arm growing out of middle of her chest wall. When she moved her true left arm, the phantom left arm moved identically. Episodes lasted less than 20 s and occurred 4 to 5 times a day. Shortly after hospitalization, the patient suffered a left radial fracture requiring cast placement. During two further spells, she reported the sensation of a cast on the supernumerary limb. Diffusion-weighted MR imaging showed a small right parietal cortical infarct. EEG revealed sharp spike activity, involving the left temporal region, and right temporal slowing. Spells resolved with initiation of phenytoin. Conclusions: In reported cases, most supernumerary phantom limb patients present with sustained pseudopolymelia in the setting of hemiplegia, sensory impairment, and anosognosia, in association with a large right hemispheric stroke. Ours is only the second case reported of recurrent, episodic supernumerary phantom limb. Our case suggests that transient supernumerary phantom limb sensations can be a manifestation of focal seizures. The case implicates in the genesis of pseudopolymelia the parietal systems responsible for sensorimotor integration and internal representation of body image.
P28. Sexual fantasy in Parkinson's disease Mi Yu, David Roane, John Rogers, Megan Fleming, Peter Homel (Beth Israel Medical Center, New York, NY)
Background: Parkinson's disease is associated with sexual dysfunction in up to 80% of patients. This study examined the biopsychosocial correlates of sexual functioning in PD, considering the effect of PD on the different phases of sexual response. Methods: 13 male and 4 female PD patients, ages 53–85, were evaluated with their partners. Measures included the Derogatis Interview for Sexual Functioning (an assessment of function across the sexual response cycle), Unified Parkinson's Disease Rating Scale, Ham-D and Ham-A, Dyadic Adjustment Scale, Social Support Questionnaire, and assessment of autonomic dysfunction. Results: Subjects demonstrated substantial impairment in the arousal, orgasm, and sexual drive phases, with most patients scoring below the first percentile on these Derogatis Interview subscales. Sexual fantasy scores, with a median percentile of 29%, allowed for meaningful correlation analysis. Fantasy scores failed to correlate with age, previous sexual experience, or current sexual behavior. Sexual fantasy tended to correlate negatively with anxiety (r=0.424, P=0.09) and positively with duration of PD (r=0.715, P<0.01). Conclusions: Sexual fantasy is relatively preserved, compared with other aspects of sexuality, in PD. The use of fantasy may actually increase with disease progression, suggesting that clinicians should attend to sexual concerns throughout the course of PD.
Dementia
P29. Does cognitive recovery after treatment of poststroke depression last? A two-year follow-up of cognitive function associated with poststroke depression Keen-Loong Chan, Robert G. Robinson, James T. Kosier (University of Iowa, Iowa City, IA; Tan Tock Seng Hospital, Singapore)
Background: Cognitive impairment is common after stroke and may be caused by poststroke depression and/or structural damage to the cerebrum. We examined the changes in cognition over 2 years after remission of poststroke depression (PSD). Methods: 12 patients with PSD and cognitive impairment who were selected on the basis of early and sustained remission of their depression were compared with 12 nondepressed stroke patients. Mood and cognition were followed up over 2 years, using the Ham-D and MMSE. Results: In patients with early and sustained remission of depression, there was rapid and early improvement of cognitive function, which was maintained over 2 years. For depressed patients, the initial MMSE score of 22.5±3.8 improved to 26.7±3.0 at 3 months and was 25.6±3.3 at 2 years. The magnitude of cognitive impairment due to depression was estimated as –3.4 points on the MMSE. Conclusions: Cognitive function, once improved after remission of PSD, is likely to remain stable over the next 2 years in the absence of subsequent reinjury to the central nervous system. Cognitive impairment due to poststroke depression is reversible and can be quantified separately from irreversible cognitive impairment due to other aspects of stroke. Support from NIMH Grants MH40355, MH52879, and MH53592.
P30. Open-label trial of guanfacine for symptomatic treatment of frontotemporal dementia Tiffany W. Chow (Rancho Los Amigos National Rehabilitation Center/University of Southern California Alzheimer's Disease Center, Los Angeles, CA)
Background: Children with attention deficit disorder (ADD) have a frontal dysexecutive syndrome similar to that of most patients with frontotemporal dementia (FTD). Treatment with alpha2 agonists, clonidine or guanfacine, improves attention and concentration ability. Guanfacine has fewer side effects in children with ADD than clonidine. It is possible that guanfacine could also address frontal dysexecutive syndrome in older adults with FTD. Methods: 14 adults with FTD syndromes (frontal lobe degeneration and primary progressive aphasias) consented to an open-label trial of guanfacine. Over a 3-month period, subjects took a maximum dose of 1 mg daily. A continuous performance task (A-test), digit span forward and reverse, Stroop C and C-W, Trails A and B, and the Neuropsychiatric Inventory were administered at baseline, 1-month, and 3-month time points. Results: Subjects with moderate to advanced illness (<111/112 on the Stroop C simple reading task) did not benefit from guanfacine at the 1-mg dose. Improvement in frontal executive function was equivocal, and caregiver distress worsened among those subjects in early to moderate stages. Conclusions: Evidence-based treatment for patients with FTD is in great demand from patients and their families. Multicenter trials using different agents or using a higher dose of guanfacine in early stages of FTD may shed more light on treatment options.
P31. A review of the memory stimulation programs in Alzheimer's disease Éric Grandmaison, Martine Simard (Université de Moncton, Moncton, Nouveau-Brunswick, Canada)
Background: The goal of this work was to qualitatively review the efficacy of the memory stimulation programs used in Alzheimer's disease. Methods: MEDLINE and PsycINFO searches were done using the following keywords: memory remediation; memory remediation and dementia; cognitive remediation; cognitive remediation and dementia (and then with “stimulation” instead of “remediation”); vanishing cues; spaced retrieval; errorless learning; cue utilization and AD; visual imagery and AD. Results: Six controlled and five randomized controlled studies as well as four studies with multiple single-case experimental design were reviewed. N per group ranged from 2 to 33 subjects. Visual imagery, the errorless learning and dyadic approaches, spaced-retrieval techniques, encoding specificity with cognitive support at retrieval, and external memory aids were the memory stimulation programs used alone or in combination in AD. Studies using the space-retrieval techniques (alone or in combination with the errorless learning approach) and the dyadic approach showed the best positive effects and long-term maintenance of the gains up to 6 and 8 months post baseline. Conclusions: Preliminary evidence suggests that the errorless learning, dyadic approach, and spaced retrieval techniques, used alone or in combination, are efficacious to stimulate memory in AD. More crossover, randomized, placebo-controlled studies, using larger sample of subjects, are needed.Support from the Jeanne et J.-Louis Levesque Doctoral Award (E.G.).
P32. Early results of the REVEAL study: risk evaluation and education for Alzheimer's disease R.C. Green, N. Relkin, P. Whitehouse, T. Brown, S. LaRusse, M. Barber, L. Farrer, L. Cupples, S. Post, L. Ravdin, D. Cisewski, H. Katzen, S. Sami, A. Sadovnick, J. Davis, K. Quaid, J. Woodard (Boston University School of Medicine, Boston, MA)
Background: The REVEAL study is a randomized controlled trial examining the impact of providing risk assessment, including apolipoprotein E (APOE) genotyping, to asymptomatic adult children of persons with Alzheimer's disease. Methods and Results: 242 REVEAL participants have been enrolled, 181 have attended the introductory educational session, 133 have proceeded through neuropsychology screening and blood draw, 113 have received results disclosure, and 102 have been seen for one or more follow-up visits. Enrolled individuals who chose not to continue through the results-disclosure step cited insurance concerns, and some changed their mind about wanting to learn risk or genotype information. Of those seen for results disclosure, 81 were randomized to receive a personalized risk estimate based on both family history and APOE genotype information. The remaining 32 participants (control group) were randomized to receive a risk estimate based on family history information only. Of those participants who have received APOE results thus far, 37 had a 3/3 genotype, 35 had 3/4, 4 had 2/3, 4 had 4/4, and 1 had 2/4. Participants' reactions to personalized risk estimates were varied and included being upset, having preconceived risk beliefs confirmed, and/or feeling reassured by the information presented. Outcome variables include measures of anxiety, depression, and satisfaction with the risk assessment and counseling protocol, as well as real-world decisions to change retirement planning or insurance coverage. Conclusions: Disclosures of APOE genotype and AD risk assessment have been well tolerated thus far. Additional results of early analyses will be presented.Support from the National Human Genome Institute and NIA.
P33. Differential performance on the Benton Judgment of Line Orientation Test in dementia with Lewy bodies and Alzheimer's disease Martine Simard, Robert van Reekum, David Myran, Michel Panisset, Sandra E. Black, Morris Freedman (Université de Moncton, Moncton, Nouveau-Brunswick, Canada)
Background: Reports of differential impairments on visual-construction tasks in dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) are sometimes controversial, and visual-perceptual data are lacking (Simard et al, J Neuropsychiatry Clin Neurosci 2000; 12:425–450). The goal of this study was to assess the visual-perceptual performance of subjects with DLB and AD. Methods: The Benton Judgment of Line Orientation Test (BJLO) was administered to 8 DLB, 13 AD, and 8 control subjects. An analysis of error types (Ska et al, J Clin Exp Neuropsychol 1990; 12:695–702) was afterwards applied to the results of the BJLO with QO1, QO2, QO3, QO4 (visual attention) errors, as well as VH, IQOV, and IQOH (visual-spatial perception) errors. Results: A MANOVA showed significant differences between the three groups on the BJLO total score (F=4.09, df=2,26, P<0.05) and the number of errors for VH (F=5.45, df=2,26, P<0.05) and IQOH (F=3.83, df=2,26, P<0.05). The t-test analyses demonstrated that subjects with DLB made significantly more VH (P<0.05) and IQOH (P<0.05) errors than subjects with AD. Compared with control subjects, both patient groups had inferior performance on the BJLO total score. Conclusions: Subjects with DLB have more severe visual-perception (VH and IQOH errors) impairments than subjects with AD.Support from Alzheimer Society of Canada.